Press Releases

CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.

Jun 23, 2022
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
Jun 16, 2022
Stem Cell Agency Joins Consortium Developing Gene Therapies for Rare Diseases
May 26, 2022
CIRM Board Approves Funding for Clinical Trials Targeting Epilepsy and Dysphagia
Apr 19, 2022
Stem Cell Agency Invests in Therapy Using Killer Cells to Target Colorectal, Breast and Ovarian Cancers
Mar 24, 2022
Stem Cell Agency Funds Research Aiming to Heal Skin Ulcers
Mar 7, 2022
Stem Cell Agency Hires New Vice President of Medical Affairs & Policy
Feb 24, 2022
Stem Cell Agency Board Approves Funding for Rare Immune Disorder
Feb 14, 2022
CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
Jan 27, 2022
Stem Cell Agency Board Approves Two Early-Stage Research Programs Targeting Cartilage Damage
Jan 24, 2022
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
Dec 14, 2021
Stem Cell Agency Board Approves Roadmap for Next Five Years; Invests $5M in High School Internships
Nov 29, 2021
Creating a New Model for Diversity in Scientific and Medical Research
Nov 23, 2021
Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers
Oct 19, 2021
Stem Cell Agency Funds Research to Repair Damaged Knee Cartilage
Sep 23, 2021
Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
Aug 24, 2021
Stem Cell Agency Funds Three New Clinical Trials at Stanford
Jul 20, 2021
Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
Jul 7, 2021
Art Torres Appointed to Two New Roles on the University of California Board of Regents
Jun 24, 2021
CIRM Adds Five New Hires, including VP Scientific Programs and a Decorated Veteran, to Build Out Its World Class Team
Jun 18, 2021
CIRM Board Approves New Clinical Trial for ALS
May 28, 2021
Statement from Dr. Maria Millan on the News of Orchard Returning the Treatment for ADA-SCID to UCLA
May 17, 2021
CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics
May 14, 2021
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
May 12, 2021
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
May 11, 2021
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
Apr 20, 2021
CIRM Board Approves Clinical Trials for Blood Cancer and Pediatric Brain Tumors
Mar 30, 2021
Three UC’s Join Forces to Launch CRISPR Clinical Trial Targeting Sickle Cell Disease
Feb 9, 2021
UCSF Nursing Professor Joins Board of California’s Stem Cell Agency
Jan 11, 2021
U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
Dec 14, 2020
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
Nov 18, 2020
CIRM-Funded Clinical Trial for Sickle Cell Gives Hope to People Battling the Disease
Nov 13, 2020
Statement on the approval of Proposition 14
Nov 12, 2020
CIRM Board Approves Four New Clinical Trials
Sep 14, 2020
CIRM Funded Trial for Parkinson’s Treats First Patient
Sep 8, 2020
California’s Stem Cell Agency and the Chan Zuckerberg Initiative Partner to Create COVID-19 Database
Aug 7, 2020
Dean of UC Davis School of Medicine Joins Stem Cell Agency Board
Jul 24, 2020
CIRM Board Approves Two New Discovery Research Projects for COVID-19
Jul 10, 2020
CIRM Board Approves Two Discovery Research Projects for COVID-19
Jun 26, 2020
CIRM Board Approves Third Clinical Trial for COVID-19
Jun 12, 2020
CIRM Board Approves Two Additional COVID-19 Projects
May 29, 2020
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
May 22, 2020
CIRM Board Expands Efforts of COVID-19 Program
May 15, 2020
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Apr 24, 2020
CIRM Board Funds its First Clinical Study for COVID-19
Apr 10, 2020
CIRM Board Expands COVID-19 Efforts
Mar 27, 2020
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
Dec 16, 2019
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
Dec 13, 2019
CIRM’s Alpha Stem Cell Clinics Given High Profile Role in Clinical Trials Network
Oct 31, 2019
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
Oct 9, 2019
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California

Pages

Media Contact

Kevin McCormack
Sr. Director Public Communications & Patient Advocate Outreach
415-361-2903
kmccormack@cirm.ca.gov